| Dr Thomas William Schmidt, MD | |
|
8421 Plum Dr, Urbandale, IA 50322-7356 | |
| (515) 274-7222 | |
| Not Available |
| Full Name | Dr Thomas William Schmidt |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 15 Years |
| Location | 8421 Plum Dr, Urbandale, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245468768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 010249008 (Virginia) | Primary |
| 208D00000X | General Practice | 0101249008 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Cass County Memorial Hospital | Atlantic, IA | Hospital |
| St Anthony Regional Hospital & Nursing Home | Carroll, IA | Hospital |
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Mercyone Newton Medical Center | Newton, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iowa Arthritis And Osteoporosis Center Pc | 0941514715 | 17 |
| Cass County Memorial Hospital | 5294634994 | 59 |
News Archive
Dementia is a syndrome consisting of a number of symptoms that include loss of memory, judgment and reasoning, and changes in mood, behaviour and communication abilities. Alzheimer Disease, the most common form of dementia, accounts for 64 per cent of all dementias in Canada.
Ophthotech Corp., a privately held biopharmaceutical company focused on developing ophthalmic therapies for back-of-the-eye diseases, today announced that the first patient has been enrolled in its Phase II randomized, controlled clinical trial of E10030, an anti-PDGF aptamer, in combination with Lucentis® for the treatment of wet age-related macular degeneration (AMD).
The success of Apple's App Store and the Android Market has inspired EU-funded developers of 'Ambient assisted-living' (AAL) solutions to develop their own open application marketplace and work together on interoperable platforms. In doing so, they are hoping to mainstream technology that will help older people live more active and comfortable lives.
Researchers have identified a new gene-activation pathway caused by lipids associated with coronary artery disease, a finding that could help identify new directions in research and drug development. The study was published in June in Nature Communications.
According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.
› Verified 6 days ago
| Entity Name | Cass County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861597122 PECOS PAC ID: 5294634994 Enrollment ID: O20031231000681 |
News Archive
Dementia is a syndrome consisting of a number of symptoms that include loss of memory, judgment and reasoning, and changes in mood, behaviour and communication abilities. Alzheimer Disease, the most common form of dementia, accounts for 64 per cent of all dementias in Canada.
Ophthotech Corp., a privately held biopharmaceutical company focused on developing ophthalmic therapies for back-of-the-eye diseases, today announced that the first patient has been enrolled in its Phase II randomized, controlled clinical trial of E10030, an anti-PDGF aptamer, in combination with Lucentis® for the treatment of wet age-related macular degeneration (AMD).
The success of Apple's App Store and the Android Market has inspired EU-funded developers of 'Ambient assisted-living' (AAL) solutions to develop their own open application marketplace and work together on interoperable platforms. In doing so, they are hoping to mainstream technology that will help older people live more active and comfortable lives.
Researchers have identified a new gene-activation pathway caused by lipids associated with coronary artery disease, a finding that could help identify new directions in research and drug development. The study was published in June in Nature Communications.
According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.
› Verified 6 days ago
| Entity Name | Iowa Arthritis And Osteoporosis Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720462914 PECOS PAC ID: 0941514715 Enrollment ID: O20150806012531 |
News Archive
Dementia is a syndrome consisting of a number of symptoms that include loss of memory, judgment and reasoning, and changes in mood, behaviour and communication abilities. Alzheimer Disease, the most common form of dementia, accounts for 64 per cent of all dementias in Canada.
Ophthotech Corp., a privately held biopharmaceutical company focused on developing ophthalmic therapies for back-of-the-eye diseases, today announced that the first patient has been enrolled in its Phase II randomized, controlled clinical trial of E10030, an anti-PDGF aptamer, in combination with Lucentis® for the treatment of wet age-related macular degeneration (AMD).
The success of Apple's App Store and the Android Market has inspired EU-funded developers of 'Ambient assisted-living' (AAL) solutions to develop their own open application marketplace and work together on interoperable platforms. In doing so, they are hoping to mainstream technology that will help older people live more active and comfortable lives.
Researchers have identified a new gene-activation pathway caused by lipids associated with coronary artery disease, a finding that could help identify new directions in research and drug development. The study was published in June in Nature Communications.
According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas William Schmidt, MD 8421 Plum Dr, Urbandale, IA 50322-7356 Ph: (515) 270-7222 | Dr Thomas William Schmidt, MD 8421 Plum Dr, Urbandale, IA 50322-7356 Ph: (515) 274-7222 |
News Archive
Dementia is a syndrome consisting of a number of symptoms that include loss of memory, judgment and reasoning, and changes in mood, behaviour and communication abilities. Alzheimer Disease, the most common form of dementia, accounts for 64 per cent of all dementias in Canada.
Ophthotech Corp., a privately held biopharmaceutical company focused on developing ophthalmic therapies for back-of-the-eye diseases, today announced that the first patient has been enrolled in its Phase II randomized, controlled clinical trial of E10030, an anti-PDGF aptamer, in combination with Lucentis® for the treatment of wet age-related macular degeneration (AMD).
The success of Apple's App Store and the Android Market has inspired EU-funded developers of 'Ambient assisted-living' (AAL) solutions to develop their own open application marketplace and work together on interoperable platforms. In doing so, they are hoping to mainstream technology that will help older people live more active and comfortable lives.
Researchers have identified a new gene-activation pathway caused by lipids associated with coronary artery disease, a finding that could help identify new directions in research and drug development. The study was published in June in Nature Communications.
According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.
› Verified 6 days ago
Gino Paul Chesini, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8421 Plum Dr, Urbandale, IA 50322 Phone: 155-270-7222 Fax: 515-270-7202 | |
Erin Jeanette Fish, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4005 Nw Urbandale Dr, Urbandale, IA 50322 Phone: 515-643-9500 Fax: 515-643-9525 | |
Wendy L Fluegel, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3112 Pine Cir, Urbandale, IA 50322 Phone: 515-240-9342 | |
Mark Burdt, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8421 Plum Dr, Urbandale, IA 50322 Phone: 515-643-9699 Fax: 515-643-9698 | |
Deana Dawn Hoganson, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8421 Plum Dr, Urbandale, IA 50322 Phone: 515-643-9699 Fax: 515-643-9698 | |
Lazaro Rabang, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4005 Nw Urbandale, Urbandale, IA 50322 Phone: 515-643-9500 Fax: 515-643-9525 |